Results 191 to 200 of about 6,616,454 (383)

SURGICAL TUBERCULOSIS IN CHILDREN, WITH SUGGESTIONS AS TO A METHOD OF TREATMENT. [PDF]

, 1913
A. H. Tubby
openalex   +1 more source

Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017

JAMA Surgery, 2017
S. Berríos-Torres, C. Umscheid, D. Bratzler, B. Leas, E. Stone, R. Kelz, C. Reinke, S. Morgan, J. Solomkin, J. Mazuski, E. Dellinger, Kamal M. F. Itani, E. Berbari, J. Segreti, J. Parvizi, Joan C. Blanchard, G. Allen, J. Kluytmans, R. Donlan, W. Schecter   +19 more
semanticscholar   +1 more source

The subcellular distribution of phosphorylated Y‐box‐binding protein‐1 at S102 in colorectal cancer patients, stratified by KRAS mutational status and clinicopathological features

Molecular Oncology, EarlyView.
This study identifies nuclear YB‐1 S102 phosphorylation as a marker associated with KRAS and FBXW7 mutations in colorectal cancer. Mutated KRAS correlates specifically with nuclear, not cytoplasmic, S102 YB‐1. These findings provide the first ex vivo evidence of this link in CRC and suggest future studies should assess the prognostic and therapeutic ...
Konstanze Lettau, Stephan Forchhammer, Birgit Fehrenbacher, Lejla Mahmutovic, Marcus Scharpf, Gunnar Blumenstock, Martin Schaller, Irina Bonzheim, Shayan Khozooei, Mahmoud Toulany   +9 more
wiley   +1 more source

SURGICAL TUBERCULOSIS IN CHILDREN. [PDF]

, 1913
PaulB. Roth
openalex   +1 more source

A Surgical Safety Checklist to Reduce Morbidity and Mortality in a Global Population

New England Journal of Medicine, 2009
A. Haynes, Thomas G. Weiser, William R. Berry, S. Lipsitz, A. Breizat, E. Dellinger, T. Herbosa, S. Joseph, P. Kibatala, M. C. M. Lapitan, A. Merry, K. Moorthy, Richard K. Reznick, Bryce R. Taylor, A. Gawande   +14 more
semanticscholar   +1 more source

Therapeutic applications of a novel humanized monoclonal antibody targeting chemokine receptor CCR9 in pancreatic cancer

Molecular Oncology, EarlyView.
C–C chemokine receptor type 9 (CCR9) is an immune checkpoint in pancreatic ductal adenocarcinoma (PDAC). Novel anti‐CCR9 antibody SRB2 was evaluated in combination with cytotoxic chemotherapy in PDAC cells, patient‐derived organoids, patient‐derived xenografts, and humanized mouse models.
Hannah G. McDonald, Anna M. Reagan, Charles J. Bailey, Mei Gao, Muqiang Gao, Angelica L. Solomon, Michael J. Cavnar, Prakash K. Pandalai, Mautin T. Barry‐Hundeyin, Megan M. Harper, Justin A. Rueckert, Ángela Turrero, Araceli Tobio, Anxo Vidal, Daniel Roca‐Lema, Elia Álvarez‐Coiradas, Pablo Garrido, Laureano Simón, Joseph Kim   +18 more
wiley   +1 more source

Three Clinical Lectures ON GENERAL SURGICAL AN qSTHESIA. [PDF]

, 1907
Fred G. Hewitt
openalex   +1 more source

Surgical or Transcatheter Aortic‐Valve Replacement in Intermediate‐Risk Patients

New England Journal of Medicine, 2017
M. Reardon, N. van Mieghem, J. Popma, N. Kleiman, L. Søndergaard, Mubashir A. Mumtaz, David H. Adams, G. Deeb, Brijeshwar Maini, H. Gada, S. Chetcuti, T. Gleason, J. Heiser, R. Lange, William M. Merhi, J. Oh, P. Olsen, N. Piazza, Mathew R. Williams, S. Windecker, S. Yakubov, E. Grube, R. Makkar, Joon S. Lee, J. Conte, E. Vang, H. Nguyen, Yanping Chang, Andrew S. Mugglin, P. Serruys, A. Kappetein   +30 more
semanticscholar   +1 more source

Unraveling LINE‐1 retrotransposition in head and neck squamous cell carcinoma

Molecular Oncology, EarlyView.
The novel RetroTest method allows the detection of L1 activation in clinical samples with low DNA input, providing global L1 activity and the identification of the L1 source element. We applied RetroTest to a real‐world cohort of HNSCC patients where we reported an early L1 activation, with more than 60% of T1 patients showing L1 activity.
Jenifer Brea‐Iglesias, Ana Oitabén, Sonia Zumalave, Bernardo Rodriguez‐Martin, María Gallardo‐Gómez, Martín Santamarina, Ana Pequeño‐Valtierra, Laura Juaneda‐Magdalena, Ramón García‐Escudero, José Luis López‐Cedrún, Máximo Fraga, José M. C. Tubio, Mónica Martínez‐Fernández   +12 more
wiley   +1 more source

THE SURGICAL SIGNIFICANCE OF PULMONARY HYPERTENSION

, 1952
William H. Muller, John F. Dammann
openalex   +2 more sources